106964 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2022-12-20 |
| Register Year | 2022 |
| Product Type | Human |
| Drug Type | Generic |
| Scientific Name | LENVATINIB |
| Trade Name | Lenvatinib TBM |
| Strength Unit | mg |
| Pharmaceutical Form | Capsule, hard |
| Administration Route | Oral use |
| Atc Code1 | L01XE29 |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Blister |
| Package Size | 30 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $4817.75 |
| Shelf Life | 24 Months |
| Marketing Company | Boston Oncology Arabia |
| Marketing Country | Saudi Arabia |
| Manufacture Name | Shilpa Medicare Ltd |
| Manufacture Country | India |
| Secondry package manufacture | Boston Oncology Arabia |
| Main Agent | Boston Oncology Arabia |
| Secosnd Agent | |
| Third Agent | |
| Visits | 106964 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| Lenvatinib TBM | $4817.75 | 106964 visits | 2022-12-20 |
| LENVIMA 10 mg HARD CAPSULES | $5161.85 | 286195 visits | 2023-03-01 |
| LENVIMA 4 mg HARD CAPSULES | $5161.85 | 132429 visits | 2023-03-01 |